Genetic specification of malignant hyperthermia susceptibility is warranted for assessing fatigue, depression, and exercise intolerance
Braz. J. Anesth. (Impr.); 73 (6), 2023
Results: 36
Predictive factors of the contracture test for diagnosing malignant hyperthermia in a Brazilian population sample: a retrospective observational study
Braz. J. Anesth. (Impr.); 73 (2), 2023
Abstract Introduction Malignant Hyperthermia (MH) is a pharmacogenetic, hereditary and autosomal dominant syndrome triggered by halogenates/succinylcholine. The In Vitro Contracture Test (IVCT) is the gold standard diagnostic test for MH, and it evaluates abnormal skeletal muscle reactions of susceptibl...
Fatigue, depression, and physical activity in patients with malignant hyperthermia: a cross-sectional observational study
Braz. J. Anesth. (Impr.); 73 (2), 2023
Abstract Background Malignant Hyperthermia (MH) is a pharmacogenetic disorder triggered by halogenated anesthesia agents/succinylcholine and characterized by hypermetabolism crisis during anesthesia, but also by day-to-day symptoms, such as exercise intolerance, that may alert the health professional. ...
Malignant hyperthermia: new knowledge changing perspectives
Braz. J. Anesth. (Impr.); 73 (2), 2023
Several challenges associated with the anesthetic management of Emery-Dreifuss muscular dystrophy patients: case report
Braz. J. Anesth. (Impr.); 73 (2), 2023
Abstract Emery-Dreifuss Muscular Dystrophy is a very rare type of muscular dystrophy, associated with contractures, atrophy, and muscle weakness, besides cardiomyopathy with severe arrhythmias. Published studies focusing on this disorder are scarce. We describe the anesthetic management of a male patient...
Patient suspected susceptibility to malignant hyperthermia: impact of the disease
Braz. J. Anesth. (Impr.); 73 (2), 2023
Abstract Introduction Malignant Hyperthermia (MH) is an inherited hypermetabolic syndrome triggered by exposure to halogenated anesthetics/succinylcholine. The lack of knowledge regarding this condition might be associated with the rare occurrence of MH reaction and symptoms. Methods This observational...
Manejo anestésico de paciente con dermatomiositis paraneoplásica en cirugía de cáncer de ovario
Rev. chil. anest; 52 (2), 2023
Dermatomyositis is a rare disease with important implications regarding the anesthetic management of the patient. The possibility of the development of hyperkalemic crises, malignant hyperthermia or myotonic crises forces us to know which drugs are safe and which ones should be avoided. The involvement o...
Manejo anestésico de paciente con dermatomiositis paraneoplásica en cirugía de cáncer de ovario
Rev. chil. anest; 52 (3), 2023
Dermatomyositis is a rare disease with important implications regarding the anesthetic management of the patient. The possibility of the development of hyperkalemic crises, malignant hyperthermia or myotonic crises forces us to know which drugs are safe and which ones should be avoided. The involvement o...
Anestesia/efectos adversos, Dermatomiositis/complicaciones, Síndromes Paraneoplásicos/complicaciones, Hiperpotasemia/etiología, Hipertermia Maligna/etiología, Neoplasias Ováricas/cirugía, Complicaciones Posoperatorias/prevención & control, Insuficiencia Renal/prevención & control, Dermatomiositis/diagnóstico, Síndromes Paraneoplásicos/diagnóstico, Anestesia/métodos, Neumonía por Aspiración, Insuficiencia Cardíaca
Malignant hyperthermia: what we may need to have at hand
Rev. colomb. anestesiol; 49 (4), 2021
Malignant hyperthermia (MH) is often neglected in anesthesia because of its rare incidence (around 1:100,000 general anesthetics). However, when it occurs, it becomes the anesthesiologist's nightmare. In the United States, Canada, and in most European countries, it is mandatory to store dantrolene wherev...
Hipertermia maligna
Rev. chil. anest; 50 (1), 2021
Carriers of malignant hyperthermia (MH), a subclinical metabolic myopathy, respond differently to the general population in response to triggering agents, such as volatile anesthetics and succinylcholine. Its incidence ranges from 1:10,000 to 1:250,000 anesthesias. Using etiological treatment, the curren...